Search research articles
Contact Us
Filters
Showing results (101-110 of 131) with videos related to
Page
of 14
Sort By:
Diabetologia
|
November 1, 2008
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial
K J Schjoedt, A S Astrup, F Persson, et al.
Diabetes/Metabolism Research and Reviews
|
March 18, 2017
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes
J A Østergaard, S Thiel, I T Hoffmann-Petersen, et al.
Diabetes
|
May 1, 1995
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
L Tarnow, F Cambien, P Rossing, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
August 16, 2000
QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes
P K Christensen, M A Gall, A Major-Pedersen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 10, 2016
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus
T M Jensen, D Vistisen, T Fleming, et al.
Diabetologia
|
July 1, 1995
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy
L Tarnow, F Cambien, P Rossing, et al.
Cardiovascular Diabetology
|
April 28, 2017
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
S A Peeters, L Engelen, J Buijs, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 31, 2015
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes
E J Swan, R M Salem, N Sandholm, et al.
Diabetologia
|
September 27, 2012
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
K D Hove, C Brøns, K Færch, et al.
Diabetologia
|
December 1, 1996
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy
H H Parving, F S Nielsen, L E Bang, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 131) with videos related to
Sort By:
Page
of 14
Diabetologia
|
November 1, 2008
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial
K J Schjoedt, A S Astrup, F Persson, et al.
Diabetes/Metabolism Research and Reviews
|
March 18, 2017
Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes
J A Østergaard, S Thiel, I T Hoffmann-Petersen, et al.
Diabetes
|
May 1, 1995
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
L Tarnow, F Cambien, P Rossing, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
August 16, 2000
QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes
P K Christensen, M A Gall, A Major-Pedersen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 10, 2016
Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus
T M Jensen, D Vistisen, T Fleming, et al.
Diabetologia
|
July 1, 1995
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy
L Tarnow, F Cambien, P Rossing, et al.
Cardiovascular Diabetology
|
April 28, 2017
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
S A Peeters, L Engelen, J Buijs, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 31, 2015
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes
E J Swan, R M Salem, N Sandholm, et al.
Diabetologia
|
September 27, 2012
Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
K D Hove, C Brøns, K Færch, et al.
Diabetologia
|
December 1, 1996
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy
H H Parving, F S Nielsen, L E Bang, et al.
Page
of 14